Viewing nowFebaro Tablet 1mg (Pitavastatin Calcium Hydrate)
Pitavastatin Calcium Hydrate 1.102mg
Tablet · Prescription medication
Anguk Pharmaceutical Co., Ltd.

MFDS item code 202102808 · Approved 2021.03.31 · Insurance code 650205780
Improvement of primary hypercholesterolemia and mixed dyslipidemia
This medication helps to lower total cholesterol, LDL-cholesterol, Apo-B protein, and triglyceride levels in patients with primary hypercholesterolemia and mixed dyslipidemia, while increasing levels of HDL-cholesterol, known as 'good cholesterol'. It is particularly aimed at controlling blood cholesterol levels in pediatric patients with heterozygous familial hypercholesterolemia aged 10 to 16 years, thereby reducing the risk of cardiovascular diseases. This medication supports dietary effects, so maintaining a healthy diet along with consistent usage is essential. It is strongly recommended for young patients showing high LDL-cholesterol levels, especially those with familial history or other cardiovascular risk factors. Overall, this medication is used to improve blood lipid levels and protect cardiovascular health.
Patients taking this drug before and during treatment must follow a standard cholesterol-lowering diet. The usual initial dose for adults is 1–2 mg of pitavastatin calcium once daily. If the reduction in LDL cholesterol is insufficient, the dose may be increased to a maximum of 4 mg daily. Adjust the dose as appropriate at intervals of 4 weeks or longer according to LDL cholesterol levels, treatment goals, and the patient's response. The therapeutic effect of this drug is maintained with continued administration.
Ages 10 ~ 16 years: Take 1 mg of pitavastatin calcium once daily. If the reduction in LDL cholesterol is insufficient, the dose may be increased to a maximum of 2 mg daily.
This medication should not be used in certain patients. For example, patients with allergies to the components of this medication, those with seriously impaired liver function, and women who are pregnant or breastfeeding should not take this medication. Additionally, patients with muscle disorders or specific genetic lactose metabolism disorders should also not be treated with this medication. Particular caution should be taken when using this medication in patients with kidney or liver issues, elderly patients, children, or those with hypothyroidism. Co-administration of this medication with certain other medications can lead to muscle damage or worsening of kidney function, therefore, consultation with a physician or pharmacist is necessary. During the use of this medication, unusual symptoms such as muscle pain, weakness, indigestion, or skin rash may occur, and patients should promptly inform their healthcare provider if these symptoms arise. Regular liver function tests should be conducted, and blood lipid levels should be monitored to evaluate the treatment effect and side effects. Pregnant women or women who may become pregnant should avoid using this medication, and if pregnancy is confirmed during treatment, it should be discontinued immediately and a physician consulted. This medication should only be carefully administered to children under the guidance of a physician, and its safety has not been established for children under 10 years of age. This medication should be stored out of reach of children, and must be kept in the original packaging to ensure safe usage. Lastly, since this medication is a treatment for hyperlipidemia, adequate testing should be conducted prior to administration, and it is important to combine its use with dietary and exercise interventions.
Not everyone experiences these, and they can vary from person to person.
This medication is sensitive to light and should be stored in a container that does not allow light to enter. Additionally, to maintain the efficacy of the medication, it should be kept in a cool room temperature, specifically between 1 and 30 degrees Celsius.
White round film-coated tablet
30 tablets/bottle, 100 tablets/bottle
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Viewing nowPitavastatin Calcium Hydrate 1.102mg
Tablet · Prescription medication
Anguk Pharmaceutical Co., Ltd.

Pitavastatin Calcium Hydrate 1mg
Tablet · Prescription medication
JW Pharmaceutical Corporation

Pitavastatin Calcium Hydrate 2mg
Tablet · Prescription medication
JW Pharmaceutical Corporation
Pitavastatin Calcium 2mg
Tablet · Prescription medication
Youngjin Pharmaceutical Co., Ltd.

Pitavastatin Calcium 2mg
Tablet · Prescription medication
Samchundang Pharmaceutical Co., Ltd.

Pitavastatin Calcium 2mg
Tablet · Prescription medication
Daewon Pharmaceutical Co., Ltd.

Pitavastatin Calcium 2mg
Tablet · Prescription medication
Samnam Pharmaceutical Co., Ltd.

Pitavastatin Calcium 2mg
Tablet · Prescription medication
Seoul Pharmaceutical Co., Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.